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Received 11 January 2011; received in revised form 4 March 2011; accepted 18 March 2011AbstractMalaria has continued to be a major global public health problem and a health concern in most of African countries. An estimated
350–500 million cases of malaria each year result in about one million deaths, mainly children under five. The rate of malaria infection
is increasing rapidly partly due to drug resistance by the Plasmodium falciparum. The cost of the current drugs is prohibitive to the poor. There
is therefore urgent need to identify new antimalarial agents that are effective, safe and affordable. In our continuous search for these new
antimalarial compounds, extracts from five medicinal plants from the Maasai community in Kenya were tested against P. falciparum (D6;
chloroquine sensitive and W2; chloroquine resistant strains). Of the tested total plant extracts, 5 crude extracts showed good antiplasmodial
activity against D6 strain of P. falciparumwith IC50 values lower or equal to 14.3 μg/ml, 2 were moderately active with IC50 values in between
26.6 and b50 μg/ml. The petroleum ether extracts of the aerial parts and roots of Fuerstia africana demonstrated high antiplasmodial activity
against the chloroquine sensitive antiplasmodial strain D6 (IC50 1.5 and 4.6 μg/ml, respectively with a selectivity index of 44 against vero
cells).Manilkara discolor also exhibited promising antiplasmodial activity especially against D6 (IC50 11.5 and 26.6 μg/ml). In addition, ethyl acetate
extract of the roots of Pentas lanceolata and the aerial parts of Sericocomopsis hildebrandtii demonstrated moderate antiplasmodial activity against D6
and W2 (IC50 14.3 and 16.51 μg/ml) respectively. F. africana therefore has high potential and can be pursued for the development of an antimalarial
drug.
© 2011 SAAB. Published by Elsevier B.V. All rights reserved.
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Malaria a preventable and curable disease causes over
1 million deaths, mostly in children below the age of 5 years,
and 350–500 million episodes of acute illness each year (WHO,
2006). This disease affects more than 50% of the World's
population, and hits tropical Africa hardest. This region bears
more than 90% of the global malaria burden (Breman et al.,
2004; WHO, 2006).⁎ Corresponding author. Tel.: +254 20 2722541; fax: +254 20 2720030.
E-mail addresses: m_kigondu@yahoo.com, ekigondu@kemri.org
(E.V.M. Kigondu).
0254-6299/$ - see front matter © 2011 SAAB. Published by Elsevier B.V. All righ
doi:10.1016/j.sajb.2011.03.008Malaria morbidity and mortality have been held in check by
the widespread availability of cheap and effective antimalarial
drugs. Resistance of Plasmodium falciparum to these drugs may
represent the single most important threat to the health of people
in tropical countries. Chloroquine (CQ) had been the mainstay
of antimalarial drug treatment for over 40 years, but resistance
became widespread (Bloland et al., 1993; WHO, 2006). In
Kenya, chloroquine (CQ) and sulphadoxine-pyrimethamine
(SP) had been the drugs of choice. Both these antimalarials
costed less than US$ 0.20 per adult treatment course, but the
drugs required to treat drug resistant falciparum malaria
(quinine, mefloquine, and halofantrine) were over ten times
more expensive and could not be afforded by most countries in
the tropics especially those in Africa. Resistance to chloroquinets reserved.
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(Ronn et al., 1996; WHO, 2003). In Kenya, the first line drug
for uncomplicated malaria is artemether-lumefantrine (Coar-
tem®) (Ministry of Health, 2006). Reports of reduced efficacy
of artemisinins against P. falciparum from Southeast Asia is
worrying (Dondorp et al., 2010; Ferrer-Rodiriguez et al., 2004;
Noedl et al., 2009).
Malaria remains a leading cause of morbidity and mortality
in Kenya, especially in young children and pregnant women.
Each year, there are over 8.2 million malaria infections. It
accounts for 30% of outpatient attendances and 19% of
admissions to health facilities (Jean-Marie, 2002; Ministry of
Health, 2006). The disease is endemic in the lowlands,
particularly the coastal strip and Lake Victoria basin where
transmission is sufficiently intense. Both incidence and
prevalence of infection reach more than 90% of the population
within 10–12 weeks after the beginning of the rainy season
(Hoffman et al., 1996; Dianne et al., 2003; Ministry of Health,
2006).
We have previously reported the antimalarial activity of
other plants from Kenya (Gathirwa et al., 2008, 2011; Irungu
et al., 2007; Kigondu et al., 2009; Kirira et al., 2006; Muregi et
al., 2003; Muthaura et al., 2007; Rukunga et al., 2008). We
have also isolated some promising antimalarial compounds
from plants (Kirira et al., 2007; Mutai et al., 2004; Rukunga
and Waterman, 1996). In continuation of our search for
antimalarial compounds/extract from folkrole plants, the
antimalarial and cytotoxicity activities of some medicinal
plant extracts previously documented by Koch et al. (2005),
used by the Maasai community in the traditional medicine in
Kenya, were determined. These included Sericocomopsis
hildebrandtii Schinz, Pentas lanceolata (Forssk.) Defleurs,
Fuerstia africana T.C.E. Friers, Manilkara discolor (Sond.) J.
H.Hemsl. and Acacia tortilis (Hayne).2. Methodology
2.1. Collection of plant materials
The plant materials were collected in Kajiado District and
identified by Mr. Patrick Kyalo Mutiso, a plant taxonomist at
the University of Nairobi. The plant material (leaves, seeds,
roots and stem) were dried and pulverized.2.2. Extraction and fractionation
500 g amount of the powder were extracted sequentially with
solvents of increasing polarity (hexane or petroleum ether,
dichloromethane or chloroform and lastly, methanol). The
extraction was done at room temperature with intermittent
shaking for 48 h. After filtration, the solutions were evaporated
completely at reduced pressure and the afforded crude extracts
were further dried under a stream of nitrogen for 24 h and used
for the biological assays. The most active extract was further
fractionated using Vacuum Liquid Chromatography (VLC).
Various combinations of solvents were used at different ratiosand similar fractions were pooled after running Thin Layer
Chromatography (TLC).2.3. Bioassay
2.3.1. In vitro determination of antiplasmodial activity
The plant extracts were assayed using an automated micro-
dilution technique to determine 50% growth inhibition of
cultured parasites (Chulay et al., 1983; Desjardins et al., 1979).
Two different strains of P. falciparum were used in this study,
the chloroquine sensitive Sierra Leone (D6) and chloroquine
resistant Indochina (W2). They were grown in a continuous
culture supplemented with mixed gas (92% nitrogen, 5% carbon
dioxide and 3% oxygen), 10% human serum and 6% hematocrit
of O+ red blood cells. Once cultures reached the optimum
growth; growth rate ≥3.0% and a parasitaemia of N3% with at
least 80% ring developmental stage present, parasite solution
was transferred to a 96 well micro-titer plate with wells pre-
coated with the test sample. The test sample was serially diluted
across the plate to provide a range of concentrations used to
determine IC50 values. Plates were incubated in a gas chamber
for 48 h after which 3H-hypoxanthine was added and parasites
allowed to grow for a maximum of 18 h. Cells were processed
with a 96 well plate harvester (MicroBeta) onto filtermat paper
(Wallac) and washed to eliminate unincorporated isotope.
Filters were measured for radio-activity in a micro-titer plate
scintillation counter (Wallac). Data from the counter was
processed using Oracle database program to determine IC50
values.2.3.2. Cytotoxicity assay procedure
The method described by Mosmann (1983) was used.
Briefly, vero cells were grown to a confluent monolayer in a
75 cm2 culture flask at 37 °C in humidified 5% CO2 in
minimum essential medium (MEM) with Eagle's salt contain-
ing 2% L-glutamine supplemented with 10% FBS (Fetal Bovine
Serum). The cells were trypsinized and 1.0 ml aliquots of
medium containing approximately 2.5×104 cells/ml seeded
into 24-well culture plates and incubated for 2 days at 37 °C
humidified 5% CO2. The medium was removed and replaced
with fresh medium containing test sample at various concen-
trations (100, 200 and 400 μg/ml prepared in MEM and 10%
bovine serum) in triplicate. For each test sample, three wells
were used as control (non-drug-treated cells). After a further
24 h incubation, the medium was aspirated from the wells and
cells removed from monolayer culture by incubating with
trypsin-EDTA (250 μL) for 5 min at 37 °C. 50 μL of the cell
suspension was then transferred into a 96 well plate. Trypan
blue (50 μL) was then added to the cell suspension in each well.
The number of viable cells was determined by counting the cells
with the aid of a haemocytometer and percentage viability
determined using the standard procedure. The concentration of
the test sample reducing cell viability by 50% (CC50 value) of
the control was estimated from a curve relating percent cell
viability to the concentration of sample.
Table 2
Percentage yields of the extracts obtained after successive extraction.
Botanical name Part % yield
PE AcOEt MeOH
Acacia tortilis (Hayne) Seeds 0.46 0.21 nd
Fuerstia africana T.C.E. Friers Aerial 0.52 1.48 6.38
Roots 0.05 0.91 4.17
Manilkara discolor (Sond.) J.H.Hemsl. Leaves 1.57 1.15 nd
Stem 0.46 0.39 nd
Pentas lanceolata (Forssk.) Defleurs Roots 2.28 0.73 28.28
Aerial 0.69 0.78 8.95
Sericocomopsis hildebrandtii Schinz Roots 0.13 0.20 4.25
Aerial 0.16 1.01 0.10
nd — not done; PE — Petroleum ether, AcOEt — Ethyl acetate, MEOH —
methanol.
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Table 1 shows the plant species and the parts of the plants,
which were collected, extracted and tested biologically. On the
other hand, Table 2 shows the amounts of raw material used for
extraction against the percentage yields of the extracts. The IC50
values and the selectivity indices (SI) of the tested successive
plant extracts are presented in Table 3. Activity of extracts is
considered high if IC50 b10, moderate between 11 and 50, mild
between 51 and 100 μg/ml and inactive N100 μg/ml (Muregi
et al., 2003). The degree of selectivity an extract shows for the
malaria parasite can be expressed by its selectivity index (SI)
value:
Selectivity index (SI)=CC50 vero cells/IC50 Plasmodium
falciparum (Koch et al., 2005).
Of the tested crude plant extracts, 3 crude extracts showed
high antiplasmodial activity against D6 strain of P. falciparum
with IC50 values lower or equal to 10 μg/ml, 4 were moderately
active with IC50 values ranging between 10 and b50 μg/ml. The
aerial parts and roots of F. africana demonstrated interesting
antiplasmodial activity against the chloroquine sensitive plasmo-
dial strain D6 (IC50 1.56±0.00 and 4.6±0.57 μg/ml, respectively
with a selectivity index of 44 against vero cells). These results
were also observed for chloroquine resistant W2 plasmodium
strain (IC50 2.5±0.4 and 6.3±0.1 μg/ml, respectively). Ethyl
acetate extract of the roots of P. lanceolata and the aerial parts of
S. hildebrandtii had moderate antiplasmodial activity against D6
and W2 (IC50 14.3±1.6 and 16.51±0.91 μg/ml respectively).
The petroleum ether extract of the aerial parts of P. lanceolata
exhibited moderate activity against theW2 (IC50 33.91±1.06 μg/
ml).M. discolor also exhibited promising antiplasmodial activity
especially against D6 (IC50 11.5±3.2 and 26.6±4.4 μg/ml, for
methanol extracts of the leaves and ethyl acetate extract of the
stem bark respectively). Extracts of P. lanceolata and S.
hildebrandtii showed weak cytotoxicity (Table 3).
Based on the high antiplasmodial activity and selectivity
index values obtained for the petroleum ether extract of the
aerial parts of F. africana, fractionation was carried out using
VLC and antiplasmodial activity and cytotoxicity of the frac-Table 1
List of plant species collected.
Botanical name Family Local name(s) Ethnome
Acacia tortilis (Hayne) Fabaceae Ses (Pokot) Malaria
Fuerstia africana
T.C.E. Friers
Lamiaceae Oloito-dor aik (Maasai),
Birirwob-Sot (Kipsigis)
and Kalaku (Kamba)
Malaria
Manilkara discolor
(Sond.) J.H.Hemsl.
Sapotaceae – Stomach
Pentas lanceolata
(Forssk.) Defleurs
Rubiaceae Olkilaki-olkerr (Maasai) Malaria
Sericocomopsis
hildebrandtii Schinz
Amaranthaceae Oloituruj-ilpeles (Maasai)
and Kinkers (Tugen)
Malaria,
effect antions was determined and compared with that of original extract
(1) as reported in Table 4.
4. Discussions
The results obtained in this study generally show that the
plant F. africana has high antiplasmodial activity. Though the
IC50 values for the cytotoxicity assay are quite low for the plant,
selectivity index N1 is an indication of minimal cytotoxicity.
Specifically, the aerial parts of F. africana exhibited strong
antiplasmodial activity against the chloroquine sensitive strain
D6 (IC50 1.56±0.00 and 4.6±0.57 μg/ml, respectively with a
selectivity index of 44 and 24 against vero cells) and against the
chloroquine resistant W2 strain (IC50 2.5±0.4 and 6.3±0.1 μg/
ml, respectively with a selectivity index of 27 and 4 against vero
cells). This is well in agreement with literature values where the
leaves of F. africana have been reported to exhibit high in vitro
antiplasmodial activity (IC50 3.8 μg/ml, CHCl3 extract) and has
displayed selectivity for the malaria parasite P. falciparum as
indicated by a lack of cytotoxicity (ED50 N20 μg/ml) against
cultured KB cells (Koch et al., 2005).
Interestingly, after carrying out fractionation of the petro-
leum ether extract of the aerial parts of F. africana, antiplas-
modial activity of the various VLC fractions was lowered (from
IC50 1.56 to values between 3.03 and 14.20 μg/ml against D6).dical use Parts collected Collection location
Kajiado, Kenya
Voucher
number
and fever Seeds Magadi road, Kajiado PGK2007/5
Aerial parts,
roots
Kibiko, Kajiado PGK2007/3
disorder Leaves, stem
bark
Ngong Forest, Kajiado PGK2007/4
and depression Aerial parts and
roots
Langata Forest, Kajiado PGK2007/2
purgative
d dysmenorrhea
Aerial parts and
roots
Magadi Road, Kajiado PGK2007/1
Table 3
Antiplasmodial and cytotoxicity activity (IC50).
Sample and tested Part used Extract P. falciparum P. falciparum Cytotoxicity of vero cells
IC50
(μg/ml)
IC50
(μg/ml)
CC50
(μg/ml)
Selectivity index
(SI)
D6 W2 D6 W2
Acacia tortilis Seeds PE N100 N100 N100 N/A
AcOEt N100 N100 N100 N/A
Fuerstia africana Aerial parts MEOH nd 38.24±4.07 N500 N/A
PE 1.56±0.00 2.5±0.4 68.37±1.39 43.83 27.35
AcOEt nd 14.02±0.26 64.72±5.57 4.62
Roots MEOH nd 29.89±3.95 366.38±2.13 – 12.26
PE 4.6±0.57 6.3±0.1 23.79±1.55 5.17 3.78
AcOEt 14.1±0.5 13.5±0.5 52.26±4.18 3.71 3.87
Manilkara discolor Leaves MEOH 11.5±3.2 69.2±0.5 N100 N/A N/A
PE 34.4±3.7 90.6±0.7 N100 N/A N/A
AcOEt 42.6±17.1 49.9±2.2 N100 N/A N/A
Stem bark MEOH N 100 N 100 N100 N/A N/A
PE 80.6±0.6 69.4±2.6 N100 N/A N/A
AcOEt 26.6±4.4 33.4±4.6 N100 N/A N/A
Pentas lanceolata Roots MEOH nd N50 N500 N/A N/A
PE 58.5±4.7 N100 N100 N/A N/A
AcOEt 14.3±1.6 37.8±16.5 N100 N/A N/A
Aerial parts MEOH nd N50 N500 N/A N/A
PE nd 33.91±1.06
AcOEt nd 37.07±0.35 N500 N/A N/A
Sericocomopsis
hildebrandtii
Roots MEOH nd N50 N500 N/A N/A
PE nd 38.9±0.92 367.1±10.37 – 9.44
AcOEt nd nd 375.3±8.10 –
Aerial parts MEOH nd N50 93.97±0.63 N/A N/A
PE nd 31.55±0.19 N500 N/A N/A
AcOEt nd 16.51±0.91 N500 N/A N/A
Chloroquine 7.20±1.43 ng/ml 55.54±0.24 ng/ml
Artemisinin 2.22±0.06 ng/ml 4.38±0.55 ng/ml
nd— not done; N/A— not applicable; PE— Petroleum ether, AcOEt— Ethyl acetate, MEOH— methanol.
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acting synergistically hence leading to high antiplasmodial
activity of the total petroleum ether extract.
Ethyl acetate extract of the roots of P. lanceolata and the
aerial parts of S. hildebrandtii exhibited moderate antiplasmo-
dial activity against D6 and W2 (IC50 14.3±1.6 and 16.51±
0.91 μg/ml) respectively. The petroleum ether extract of theTable 4
Antiplasmodial and cytotoxicity activity of aerial parts of Fuerstia africana
fractions.
Extract IC50
(μg/ml)
Cytotoxicity for vero cells
D6 CC50
(μg/ml)
Selectivity index
(SI)
1 Pet ether extract 1.56±0.00 68.37±1.39 43.83
2 Diethyl ether 100% 3.03±0.01 105.84±3.28 34.93
3 Pet ether 100% 3.11±0.03 40.43±1.47 13.0
4 Pet ether:Chloroform 1:1 3.80±1.26 48.56±0.62 12.78
6 Ethyl acetate 100% 6.51±0.17 12.03±0.01 1.85
7 Ethyl acetate:methanol 1:1 7.10±0.06 25.63±1.54 3.61
8 Methanol 100% 14.20±4.7 26.55±2.85 1.87
nd— not done.aerial parts of P. lanceolata was also showing moderate activity
against the W2 (IC50 33.91±1.06 μg/ml). However, the roots of
P. lanceolata and S. hildebrandtii have been reported to exhibit
high in vitro antiplasmodial activity (IC50 5.2 and 3.8 μg/ml,
CHCl3 extract) and have also displayed selectivity for the
malaria parasite P. falciparum as indicated by a low cytotoxicity
(ED50 N20 μg/ml) against cultured KB cells (Koch et al., 2005).
The difference between the literature values and the results
obtained may be due to the fact that the plants in the current
study and those of literature were collected during different
seasons of the year. This leads to differences in chemical pro-
files of the extracts from the plants hence a difference in
biological activities. No literature information has been found
forM. discolor which, in the current study, was exhibiting some
promising antiplasmodial activity.
Previous chemical investigation on the leaves of P.
lanceolata revealed the presence of asperuloside, an iridoid
monoterpene and a series of iridoid glucosides (Inouye et al.,
1988; Schripsema et al., 2007). An antimalarial abietane diter-
pene has been isolated from F. africana (Koch et al., 2006).
Isolation of active compounds from the various plants in this
study has not been exhaustively achieved according to
literature, and hence they should be pursued further.
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The results obtained do establish that F. africana has a lot of
potential and can be pursued for the development of an
antimalarial drug. It is also clear from the findings in this study
that an extract of F. africana, as a whole may have better
efficacy. It would also be necessary to carryout combination
antiplasmodial activity studies of the plants to establish any
synergistic effects that could lead to better activity.Acknowledgments
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